retatrutide weight loss trial results just delivered the first top-line Phase 3 for a triple agonist in obesity β and the findings from TRIUMPH-4 are strikingπ Weight loss with retatrutide as
Description
The company references a figure of "20-25% average body weight loss" for tirzepatide

Liraglutide also reduces the secretion of monocyte chemotactic protein 1, which in turn affects the migration and activation of monocytes and macrophages [65,67]

[DOI] [PubMed] [Google Scholar] 78

2 Additionally, GLP-1 receptor agonists have the added benefit of weight loss
Simply take 1 capsule with water once a day to naturally support your fitness journey